Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Nanotechnology ; 32(48)2021 Sep 08.
Artículo en Inglés | MEDLINE | ID: covidwho-1328908

RESUMEN

The COVID-19 outbreak is creating severe impressions on all facets of the global community. Despite strong measures worldwide to try and re-achieve normalcy, the ability of SARS-CoV-2 to survive sturdy ecological settings may contribute to its rapid spread. Scientists from different aspects of life are working together to develop effective treatment strategies against SARS-CoV-2. Apart from using clinical devices for patient recovery, the key focus is on developing antiviral drugs and vaccines. Given the physical size of the SARS-CoV-2 pathogen and with the vaccine delivery platform currently undergoing clinical trials, the link between nanotechnology is clear, and previous antiviral research using nanomaterials confirms this link. Nanotechnology based products can effectively suppress various pathogens, including viruses, regardless of drug resistance, biological structure, or physiology. Thus, nanotechnology is opening up new dimensions for developing new strategies for diagnosing, preventing, treating COVID-19 and other viral ailments. This article describes the application of nanotechnology against the COVID-19 virus in terms of therapeutic purposes and vaccine development through the invention of nanomaterial based substances such as sanitizers (handwashing agents and surface disinfectants), masks and gowns, amongst other personal protective equipment, diagnostic tools, and nanocarrier systems, as well as the drawbacks and challenges of nanotechnology that need to be addressed.


Asunto(s)
Antivirales/uso terapéutico , Tratamiento Farmacológico de COVID-19 , Vacunas contra la COVID-19/uso terapéutico , Sistemas de Liberación de Medicamentos , Nanoestructuras/uso terapéutico , Pandemias/prevención & control , SARS-CoV-2/metabolismo , Animales , COVID-19/epidemiología , COVID-19/metabolismo , COVID-19/terapia , Humanos , Nanotecnología
2.
Viruses ; 13(6)2021 06 15.
Artículo en Inglés | MEDLINE | ID: covidwho-1270129

RESUMEN

Influenza is a highly known contagious viral infection that has been responsible for the death of many people in history with pandemics. These pandemics have been occurring every 10 to 30 years in the last century. The most recent global pandemic prior to COVID-19 was the 2009 influenza A (H1N1) pandemic. A decade ago, the H1N1 virus caused 12,500 deaths in just 19 months globally. Now, again, the world has been challenged with another pandemic. Since December 2019, the first case of a novel coronavirus (COVID-19) infection was detected in Wuhan. This infection has risen rapidly throughout the world; even the World Health Organization (WHO) announced COVID-19 as a worldwide emergency to ensure human health and public safety. This review article aims to discuss important issues relating to COVID-19, including clinical, epidemiological, and pathological features of COVID-19 and recent progress in diagnosis and treatment approaches for the COVID-19 infection. We also highlight key similarities and differences between COVID-19 and influenza A to ensure the theoretical and practical details of COVID-19.


Asunto(s)
COVID-19/epidemiología , Subtipo H1N1 del Virus de la Influenza A/patogenicidad , Gripe Humana/epidemiología , SARS-CoV-2/patogenicidad , Salud Global , Humanos , Pandemias/prevención & control , Pandemias/estadística & datos numéricos , Organización Mundial de la Salud
4.
Hosts and Viruses ; 7(4):91-96, 2020.
Artículo en Inglés | ProQuest Central | ID: covidwho-952949

RESUMEN

Theaim of this study was to analyse the strike of severe novel coronavirus outbreak (COVID-19) on domestic students who were at high risk of exposure. A cross sectional study was conducted through a semi structured questionnaire. Recruitment of participants was done from different universities of Pakistan. The results showed that the students are more concerned about their family members (p=0.00). Under this influence they have increased the frequency of handwashing and use masks when they have to go outside. More than half of the students (53.09%) were afraid of the COVID-19 and similar pattern was noted about depression (54.86%). About 57.5% students were willing to take part in online classes, and only 23% found to have some sort of online learning experience. Students were willing to join the volunteer force (82.3%) if they were asked in case of emergency. During COVID-19 outbreak, students should be provided individual social support and urge to obey the precautionary measures to avoid pandemic.

5.
Phytomedicine ; 85: 153277, 2021 May.
Artículo en Inglés | MEDLINE | ID: covidwho-643666

RESUMEN

The world is witnessing a difficult time. The race of developing a new coronavirus (COVID-19) vaccine is becoming more urgent. Many preliminary studies on the pathophysiology of COVID-19 patients have provided some clues to treat this pandemic. However, no suitable treatment has found yet. Various symptoms of patients infected with COVID-19 indicated the importance of immune regulation in the human body. Severe cases admitted to the intensive care unit showed high level of pro-inflammatory cytokines which enhanced the disease severity. Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients is another critical factor of disease severity and mortality. So, Immune modulation is the only way of regulating immune system. Nigella sativa has been used for medicinal purposes for centuries. The components of this plant are known for its intense immune-regulatory, anti-inflammatory, and antioxidant benefits in obstructive respiratory disorders. A molecular docking study also gave evidences that N. sativa decelerates COVID-19 and might give the same or better results than the FDA approved drugs. The aim of this review was to investigate the possible immune-regulatory effects of N. sativa on COVID-19 pandemic. Our review found N. sativa's Thymoquinone, Nigellidine, and α-hederin can be a potential influencer in reinforcing the immune response on molecular grounds.


Asunto(s)
Tratamiento Farmacológico de COVID-19 , Sistema Inmunológico/efectos de los fármacos , Nigella sativa/química , Extractos Vegetales/farmacología , Animales , Antiinflamatorios/farmacología , Antioxidantes/farmacología , Benzoquinonas/farmacología , Evaluación Preclínica de Medicamentos , Humanos , Simulación del Acoplamiento Molecular , Ácido Oleanólico/farmacología , Pandemias , SARS-CoV-2/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA